Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
AIM
AIM News & Events
-
Add to Watchlist
Trade AIM Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
AIM News
AIM ImmunoTech Completes First Dose in DURIPANC Trial
Jun 22 2026
NASDAQ.COM
AIM ImmunoTech Launches DURIPANC Clinical Trial for Pancreatic Cancer
Jun 18 2026
Newsfilter
AIM ImmunoTech Regains NYSE Compliance
Jun 16 2026
NASDAQ.COM
AIM ImmunoTech Secures $2.65 Million Financing
Jun 09 2026
seekingalpha
AIM ImmunoTech Announces $2.65 Million Financing
Jun 09 2026
Newsfilter
AIM ImmunoTech Reports Positive Clinical Progress in Pancreatic Cancer Study
Jun 08 2026
Newsfilter
Aimia Receives Approval for 5 Million Share Buyback
Jun 04 2026
Yahoo Finance
AIM ImmunoTech Hits Key Enrollment Milestone in Pancreatic Cancer Trial
Jun 01 2026
stocktwits
Show More News
AIM Events
No data
AIM Monitor News
AIM ImmunoTech Advances DURIPANC Trial for Pancreatic Cancer
Jun 24 2026
AIM ImmunoTech Launches DURIPANC Clinical Trial for Pancreatic Cancer
Jun 18 2026
AIM ImmunoTech announces $2.65 million financing deal
Jun 16 2026
AIM ImmunoTech secures $2.65 million financing to boost R&D
Jun 15 2026
AIM ImmunoTech Secures $2.65 Million Financing
Jun 11 2026
AIM ImmunoTech Secures $2.65 Million Financing
Jun 10 2026
AIM ImmunoTech Secures $2.65 Million Financing for R&D
Jun 09 2026
AIM ImmunoTech Reports Positive Clinical Progress in Pancreatic Cancer Study
Jun 08 2026
Show More Monitor News
AIM Earnings Analysis
No Data
People Also Watch
